T-Mobile US Inc. buy BiotechBee
Summary
This prediction ended on 05.05.23 with a price of €127.92. With a performance of -8.76%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionT-Mobile US (Symbol: TMUS) is a leading American telecommunications company providing wireless voice, messaging, and data services to millions of customers across the United States. Known for its innovative and customer-centric approach, TMUS operates under the flagship brand T-Mobile and also includes other prominent subsidiaries like Metro by T-Mobile, offering a diversified range of mobile services and solutions. As the third-largest wireless carrier in the US, T-Mobile US has consistently spearheaded the industry's evolution with its rapid expansion of 5G networks, competitive pricing strategies, and unique promotional offers, catering to both individual and business clients. With a strong financial performance and a commitment to excellent customer service, T-Mobile US plays a significant role in shaping the future of wireless communications in the country.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
T-Mobile US Inc. | 0.774% | 0.774% | 45.528% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
According to BiotechBee what are the pros and cons of T-Mobile US Inc. for the foreseeable future?
Pros
Cons
Comments by BiotechBee for this prediction
In the thread T-Mobile Us Inc. diskutieren
In the thread Trading T-Mobile US Inc.